CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company
Mereo BioPharma Group plc
Sign in to watch- Ticker
- MREO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 4403330237300
- Business address
- ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Bender Jeremy Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | Bender Jeremy Director | Grant or award · Deferred Restricted Stock Units | +117,533 | 117,533 | ||
| 2026-02-26 | Jenkins Annalisa Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | Jenkins Annalisa Director | Grant or award · Deferred Restricted Stock Units | +106,848 | 106,848 | ||
| 2026-02-26 | Jacquet Pierre Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | Jacquet Pierre Director | Grant or award · Deferred Restricted Stock Units | +106,848 | 106,848 | ||
| 2026-02-26 | Yoskowitz Marc J Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | Yoskowitz Marc J Director | Grant or award · Deferred Restricted Stock Units | +96,163 | 96,163 | ||
| 2026-02-26 | Shames Daniel Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | Shames Daniel Director | Grant or award · Deferred Restricted Stock Units | +96,163 | 96,163 | ||
| 2026-02-26 | Ekblom Anders Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | Ekblom Anders Director | Grant or award · Deferred Restricted Stock Units | +133,560 | 133,560 | ||
| 2026-02-26 | PAKIANATHAN DEEPIKA Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-26 | WYZGA MICHAEL S Director | Grant or award · Share Options (Right to buy) | +66,000 | 66,000 | ||
| 2026-02-01 | Lewicki John A. Chief Scientific Officer | Grant or award · Share Options (Right to buy) | +139,913 | 139,913 | ||
| 2026-02-01 | Lewicki John A. Chief Scientific Officer | Grant or award · Share Options (Right to buy) | +46,637 | 46,637 | ||
| 2026-02-01 | Lewicki John A. Chief Scientific Officer | Grant or award · Share Options (Right to buy) | +145,000 | 145,000 | ||
| 2026-02-01 | Hughes-Wilson Alexandra See Remarks | Grant or award · Share Options (Right to buy) | +183,750 | 183,750 | ||
| 2026-02-01 | Hughes-Wilson Alexandra See Remarks | Grant or award · Share Options (Right to buy) | +61,250 | 61,250 | ||
| 2026-02-01 | Hughes-Wilson Alexandra See Remarks | Grant or award · Share Options (Right to buy) | +195,000 | 195,000 |
Page 1 of 7 · 139 trades